CS269008B1 - Method of preparation of 4-tar d row 1t ha f e r A nu - Google Patents
Method of preparation of 4-tar d row 1t ha f e r A nu Download PDFInfo
- Publication number
- CS269008B1 CS269008B1 CS858480A CS848085A CS269008B1 CS 269008 B1 CS269008 B1 CS 269008B1 CS 858480 A CS858480 A CS 858480A CS 848085 A CS848085 A CS 848085A CS 269008 B1 CS269008 B1 CS 269008B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- extracted
- soil
- filtrate
- withaferin
- ethanol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sposob příprsvy 4-dehydrow!thafer1 nu A tik, le sa do tekutého aédla obsahujůceho zdroj uhlíka s organického duslks naočkuj· kuttůrs Arthrobactervs1aplex /ATCC 6946/, potoa ss přídi 10 ai 50 ag wlthaferlnu A na 100 »1 pody a nechi sa prj teplote 28 ai 30 °C kultivovat 30 ai 48 hodin. liskaný flltrét vyŤeraentovanej pody sa extrahuje ésteral kyseliny octovej, extrakt sa odpaří do sucha, získaný odparok sa přečíst! na štipci »1l1kagélu, získaný eluit sa odpař! do sucha a produkt sa kryitallzuje zo zaesl etanol: chloroform pr! 4 °C. Flltrét feraentovanej pody sa mole extrahovat aj chlorovanými uhlovodík*! s počtom 1 ai 5 uhtlkov s výhodou d1chlóraetinoaThe method of preparation of 4-dehydrow!thaferin A tic, the liquid food containing a source of carbon and organic nitrogen is inoculated with Arthrobacter v1aplex /ATCC 6946/, then with the addition of 10 and 50 g of wilthaferlin A per 100 »1 pods and not cultured at a temperature of 28 and 30 °C for 30 ai 48 hours. The polished filtrate of the treated pod is extracted with acetic acid ester, the extract is evaporated to dryness, the obtained vapor is read! on a pinch of »1l1kagel, the eluate obtained was evaporated! to dryness and the product is crystallized from ethanol: chloroform pr! 4 °C. Flttrét of feraentated pods can also be extracted with chlorinated hydrocarbons*! with the number of 1 and 5 carbon atoms, preferably d1chloroethinoa
Description
Vynález ta týká sposobu přípravy aetabelitu 4-dehydrowithaferinu A inhibujúceho buňky leukéaie P388, který sa připraví transforaác1ou withaferinu A aikroorganlzbob Arthrobacter siaplex /ATCC 6946/.The invention relates to a method for the preparation of a tablet of 4-dehydrowithaferin A inhibiting leukemia cells P388, which is prepared by transforming withaferin A into the microorganism Arthrobacter siaplex /ATCC 6946/.
Withaferin A je steroidný laktón, ktorý inhibuje rast viacerých nádorov /Shohat ♦ t.al., Cancer Cheaother. Rep., JI,271,1977 ; Fu»ka et at., Heoplasaa 31 , 31,1984 / . Látka bola Izolovaná z roznych druhov rastlin. Mlkroorganlnu: Cunn1ngha<lla elegans /HRRL 1393/ transformuje withaferin A na 15 /3-hydroxywithaferin A /Rosazza at al., Steroids 31 ,676,1978/ a na 12 A-hydroxyw1thaferin A /Fuška et al.. Steroids 35,157,1982/. Salite aetabolity z withaferinu A bolí připravené z withaferinu A pomocou Arthrobacter staple» aviak ích Struktura nebola doteraz vyrleSená /Fuška et al., Folia nicrobiol., 30, 427,1985/.Withaferin A is a steroid lactone that inhibits the growth of several tumors /Shohat ♦ t.al., Cancer Cheaother. Rep., JI,271,1977 ; Fuska et al., Heoplasaa 31 , 31,1984 /. The substance has been isolated from various plant species. Microorganism: Cunnighala elegans /HRRL 1393/ transforms withaferin A into 15 /3-hydroxywithaferin A /Rosazza at al., Steroids 31 ,676,1978/ and into 12 A-hydroxywithaferin A /Fuska et al.. Steroids 35,157,1982/. Salt metabolites of withaferin A have been prepared from withaferin A using Arthrobacter staple» and their structure has not been determined yet /Fuška et al., Folia microbiol., 30, 427,1985/.
V predkladanoa rieSeni uvádzaae spósob přípravy 4-dehydrowithaferinu A, ktorý aá vyiiiu protinádorovu aktivitu ako doteraz připravená deriváty withaferinu A i saaotný withaferin A. Podstatou náiho rieSenia je, že sa do živnej pody obsahujúcej zdroj uhl tka a organického dusika, naočkovanej kultúrou Arthrobacter siaplex /ATCC 6946/ přidá withaferin A /10- 50 ag.lOOml ^/ rozpuštěný v polárnoa rozpúštadle, s výhodou v diaety Iforaaeide a kultivuje sa 30 - 48 hodin pri teplete 28 - 30 °C za neustálého aieiania a prevzduJnovania. Filtrát feraentovanej pody, ktorý obsahuje nový aetabolit sa extrahuje ésterai kyseliny octovej, s výhodou octanoa etylnatýa a získaný extrakt sa po vysuieni odpaří do sucha, přečisti na štipci silikagelu a získaný eluát po zahuštěni pri teplote do 40 °C sa ponechá pri 4 °C, č1a sa ziska čistý 4-dehydrowithaferin A. Na extrakciu látky z filtrátu aožno taktiež použil rožne chlorované uhlovodíky s počtoa uhllkov 1 - 5 s výhodou dichlóraetánu. Ha rekryJtalizáciu aetabolitu je -výhodná zaes rozpúitadiel octan etylnatý: n-heptán alebo octan etylnatý: etanol.The present solution describes a method for preparing 4-dehydrowithaferin A, which has higher antitumor activity than previously prepared withaferin A derivatives and withaferin A. The essence of our solution is that withaferin A (10-50 mg/lOOml) dissolved in a polar solvent, preferably in a diet of Iforaaeide, is added to a nutrient medium containing a source of carbon and organic nitrogen, inoculated with a culture of Arthrobacter siaplex /ATCC 6946/ and cultivated for 30-48 hours at a temperature of 28-30 °C with constant stirring and aeration. The filtrate of the fermented soil, which contains the new metabolite, is extracted with acetic acid ester, preferably ethyl acetate, and the obtained extract is evaporated to dryness after drying, purified on a silica gel plug, and the obtained eluate, after concentration at a temperature of up to 40 °C, is left at 4 °C, until pure 4-dehydrowithaferin A is obtained. Various chlorinated hydrocarbons with a carbon number of 1-5, preferably dichloroethane, can also be used for extracting the substance from the filtrate. For the recrystallization of the metabolite, ethyl acetate: n-heptane or ethyl acetate: ethanol are preferred solvents.
4-d»hydrowithaferin A /1/ je biela kryitalická látka, t.t. 276 - 277 °C, suaárnaho vzorca C oH_,0,. V sústave chlorofora: aeetón /4 : 2/ dává látka po detekcii p-anizaldehyi O j O o doa jednu ikvrnu hnedtj farby s hodnotou R^ 0,61. Hodnoty H-NMR spektier 4-dehydrowithaferinu A /1/ a withaferinu A /2/, na základe kterých bola látka identifikovaná sú uvedené v nasledujucej tabulke:4-dehydrowithaferin A /1/ is a white crystalline substance, mp 276 - 277 °C, of the formula C o H_,0,. In the system chloroform: acetone /4 : 2/ the substance gives after detection of p-anisaldehyde O j O o doo one icolor brown color with the value of R ^ 0.61. The values of the H-NMR spectra of 4-dehydrowithaferin A /1/ and withaferin A /2/, on the basis of which the substance was identified, are given in the following table:
ProtonProton
Mu11 i plic i taMu11 and lung and ta
2d .dd2d .dd
4d4d
6s.br.6s.br.
18s18s
6,216.21
6,946.94
3,773.77
3,233.23
0,710.71
6,876.87
3,433.43
0,740.74
S J2z3 = 10Hz; J3z4 - 6Hz; J20z21 = 6,5Hz; = 3Hz; J22z23a = 13Hz; = = 3H2> J23a,23b = 18H2>SJ 2z3 = 10Hz; J 3z4 - 6Hz; J 20z21 = 6.5Hz; = 3Hz; J 22z23a = 13Hz; = = 3H2 > J 23a,23b = 18H2 >
4-dehydrow11hafer 1n A Inhiboval v koncentrácia ch nižiích ako lO^g.ml' biochemické funkcie a rast buntek leukémie P388 výraznejile ako póvodný withaferin A a iné t neho doteraz připravené deriváty. Nail použitý mikroorganizmus transformuje velmi selektivně a za krátku dobu kulťivácie withaferin A na 4-dehydrowithafer 1 n A.4-dehydrowithaferin A inhibited the biochemical functions and growth of P388 leukemia cells at concentrations lower than 10 μg.ml more significantly than the original withaferin A and other derivatives prepared so far. The microorganism used transforms withaferin A very selectively and in a short period of cultivation into 4-dehydrowithaferin A.
V nasledujúc1ch příkladech je uvedený spísob transformácie withaferinu A na 4-dehydrow 1 thaferin A a jeho izolácia.The following examples describe the transformation of withaferin A into 4-dehydrowithaferin A and its isolation.
Přiklad 1Example 1
Do 20 varných baniek s plochým dnem o objeme 500 ml sa připravilo 100 ml pody, ktoré mala nasledujúce zloženie: glukóza 2 g, kukuřičný výluh /50 X suilny/ 3 g, kvasničný extrakt 5 g, vodovodné voda do 1000 ml, pH 6,5 -7,0. Podá sa sterilizovala 20 minut pri 120 °C a po ochladeni sa očkovala 15 ml vegetativneho inokula Arthrobacter simplex /ATCC 6946/ a kultivovala sa na rotainej trepaíke 220 ot.min \ pri teplota 28 °C. Po 24 hodinách sa do každej banky přidalo 30 mg withaferinu A rozpuštěného v 0,3 ml'dimetylformamidu. Kultivácía sa ukončila v 32 hodině kultiváeie, kedy bol přidaný substrát úplné transformovaný.Into 20 flat-bottomed boiling flasks with a volume of 500 ml, 100 ml of media was prepared, which had the following composition: glucose 2 g, corn extract /50 X suilny/ 3 g, yeast extract 5 g, tap water to 1000 ml, pH 6.5 -7.0. The media was sterilized for 20 minutes at 120 °C and after cooling, 15 ml of vegetative inoculum of Arthrobacter simplex /ATCC 6946/ was inoculated and cultivated on a rotary shaker at 220 rpm \ at a temperature of 28 °C. After 24 hours, 30 mg of withaferin A dissolved in 0.3 ml of dimethylformamide was added to each flask. The cultivation was terminated at 32 hours of cultivation, when the added substrate was completely transformed.
Přiklad 2Example 2
2000 ml média, ktoré aa získalo po ukončeni transformác1e sa centrifugovanim a následnou filtráciou zbavilo bakteriálnej biomasy. Získaný filtrát 1600 ml, pH 8,8 po úprave pH na 6,5 extrahoval třikrát po.sebe 800 ml octanu etylnatého, za neustálého mleSania, pri teplote 20 - 24 °c po dobu 15 - 20 minút. Získané extrakty sa spojili, přídavkem bezvodného síranu sodného vysušili a za zniženého tlaku při teplote do 40 °C zbavili rozpúitadla’. Získalo sa 190 mg surového produktu, ktorý sa přečistil na štipci s111kagelu /60/120 mesh, kolona 4x35 cm/, e lučné činidlo zmes octanu etylnatého » acetonu /2 : 1/. Frakcie, ktoré obsahovali 4-dehydrowithaferin A sa spojili, zbavili rozpúítadiel a pevný zbytek sa rtkryštalizoval zo zmesi etanol : octan etylnatý. Získalo sa 120 mg čistej kryštalickej látky, ktorá bola identifikovaná ako 4-dehydrowithaferin A.2000 ml of the medium obtained after the transformation was centrifuged and then filtered to remove bacterial biomass. The obtained filtrate 1600 ml, pH 8.8 after adjusting the pH to 6.5, was extracted three times with 800 ml of ethyl acetate, with constant stirring, at a temperature of 20-24 °C for 15-20 minutes. The obtained extracts were combined, dried by adding anhydrous sodium sulfate and freed from the solvent under reduced pressure at a temperature of up to 40 °C. 190 mg of crude product was obtained, which was purified on a silica gel pad /60/120 mesh, column 4x35 cm/, eluent mixture of ethyl acetate » acetone /2:1/. The fractions containing 4-dehydrowithaferin A were combined, the solvents were removed, and the solid residue was recrystallized from ethanol:ethyl acetate to give 120 mg of pure crystalline material, which was identified as 4-dehydrowithaferin A.
Přiklad 3Example 3
Postup biotransformác1e bol rovnaký ako je uvedený v přiklade 1, ale na extrakciu metabolitu sa použil dichlórmetán.The biotransformation procedure was the same as that described in Example 1, but dichloromethane was used for metabolite extraction.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS858480A CS269008B1 (en) | 1985-11-25 | 1985-11-25 | Method of preparation of 4-tar d row 1t ha f e r A nu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS858480A CS269008B1 (en) | 1985-11-25 | 1985-11-25 | Method of preparation of 4-tar d row 1t ha f e r A nu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS848085A1 CS848085A1 (en) | 1989-09-12 |
| CS269008B1 true CS269008B1 (en) | 1990-04-11 |
Family
ID=5435358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS858480A CS269008B1 (en) | 1985-11-25 | 1985-11-25 | Method of preparation of 4-tar d row 1t ha f e r A nu |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS269008B1 (en) |
-
1985
- 1985-11-25 CS CS858480A patent/CS269008B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS848085A1 (en) | 1989-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3897306A (en) | 7-Hydroxy-delta 8-tetrahydrocannabinols and microbiological production thereof | |
| JPS5898091A (en) | Triene antibiotic and preparation thereof | |
| CZ390592A3 (en) | Process for preparing 4,5-dihydrogendanamycin and hydroquinone thereof and the use of such compounds | |
| JPH0631279B2 (en) | Antibacterial / antitumor compound and method for producing the same | |
| US4994578A (en) | Certain anti-tumor duocarmycin antibiotics from streptomyces | |
| US3973608A (en) | Microbial production of certain isoflavones | |
| EP0339681B1 (en) | Antitumor antibiotic substance | |
| US3974184A (en) | Microbial production of certain isoflavones | |
| US4138481A (en) | Antibiotic BL580Δ and method of use | |
| JPS61216692A (en) | Cl-1577-b4 compound and its production | |
| US4487761A (en) | Dopamine β-hydroxylase inhibitors | |
| US4771070A (en) | CL-1957A antibiotic compound | |
| EP0139458B1 (en) | An antibiotic compound and its production | |
| CS269008B1 (en) | Method of preparation of 4-tar d row 1t ha f e r A nu | |
| US3616237A (en) | Method of preparing thiogriseofulvins | |
| Kurasawa et al. | Studies on glyoxalase inhibitor isolation of a new active agent, MS-3, from a mushroom culture | |
| EP0001287B1 (en) | Antibiotic no. 2-200, process for its production and pharmaceutical compositions containing antibiotic no. 2-200 | |
| EP0139457A2 (en) | An antibiotic compound and its production | |
| US3692777A (en) | 5h-pyrrolo {8 2,1-c{9 {8 1,4{9 {0 benzodiazepin-5-ones | |
| EP0205339A1 (en) | Antimicrobial and antitumor phenazine carboxaldehydes and derivatives | |
| US4232006A (en) | Antibiotic W-10 complex, antibiotic 20561 and antibiotic 20562 as antifungal agents | |
| US4137224A (en) | Process for the preparation of antibiotic W-10 complex and for the isolation of antibiotic 20561 and antibiotic 20562 therefrom | |
| US4189537A (en) | Process of producing antibiotic BL580Δ with Streptomyces hygroscopicus | |
| EP0046641A2 (en) | Novel antibiotics, the microbiological preparation of antibiotics, and a novel microorganism | |
| EP0303250A2 (en) | Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same and a process for its preparation |